ADVFN US – Market Content Editor
-
Nvidia’s Blockbuster Outlook Reignites the AI Trade, Powering Nasdaq to a 1.6% Gain
Wall Street closed higher on Thursday as a stronger-than-expected forecast from Nvidia revived enthusiasm for the artificial intelligence trade that has driven the bull market. Technology shares led the advance, with the Nasdaq Composite outpacing the broader market by a wide margin, while gains in the Dow Jones Industrial Average were more restrained. The rally…
-
AITX’s RAD Records 14-Unit Order Intake Across Five Customer Relationships
AITX subsidiary RAD received orders for 14 security units across five customer relationships within 24 hours, with the deployments expected to generate approximately $150,000 in annualized recurring revenue if all units are successfully placed into service under their current terms. Key Investor Takeaways Why AITX Stock Is in Focus Artificial Intelligence Technology Solutions (USOTC:AITX) said…
-
Black Dragon Texas Frac Sand Acquisition Stays on Track as Share Buyback Nears
Black Dragon Resource Companies said its Texas frac sand acquisition remains on schedule while an open-market share buyback is set to begin August 31, putting transaction completion, resource development and capital management in focus for shareholders. Key Investor Takeaways Why BDGR Stock Is in Focus Black Dragon Resource Companies (USOTC:BDGR) provided investors with updates on…
-
American Fusion Reports 100,000-Atmosphere Texatron Testing as D–³He Fusion Program Advances
American Fusion reported repeatable peak confinement pressures of approximately 100,000 atmospheres from its Texatron testing program, while stressing that significant scientific and engineering milestones remain before D–³He fusion ignition or net energy gain can be demonstrated. Key Investor Takeaways Why AMFN Stock Is in Focus American Fusion (USOTC:AMFN) has provided new testing and modeling results…
-
Propanc Biopharma Reports PRP Preclinical Pancreatic Cancer Data Showing Over 90% Tumor Growth Inhibition
Propanc Biopharma reported new preclinical pancreatic cancer data showing more than 90% mean tumor growth inhibition and a greater than 2.5-fold survival benefit for PRP, providing additional support as the company prepares its lead candidate for a planned Phase 1b study. Key Investor Takeaways Why PPCB Stock Is in Focus Propanc Biopharma (NASDAQ:PPCB) reported additional…
-
Kraken Robotics Q2 Revenue Rises as $355 Million Order Total Supports Growth Outlook
Kraken Robotics delivered higher second-quarter revenue, gross profit and Adjusted EBITDA while maintaining its 2026 guidance, with approximately $355 million of announced orders on a combined basis with newly acquired Covelya Group strengthening visibility into future demand. Key Investor Takeaways Why KRKNF Stock Is in Focus Kraken Robotics (USOTC:KRKNF) generated second-quarter revenue of C$27.3 million,…
-
Celularity Signs U.S. Manufacturing Collaboration With Potential $300 Million Purchase Opportunity
Celularity’s new manufacturing collaboration with MuseCell Innovations is intended to establish U.S. production for the Dezawa MuseCell platform, with MCI projecting that a broader relationship could generate more than $300 million in aggregate purchases from Celularity over five years. Key Investor Takeaways Why CELU Stock Is in Focus Celularity (NASDAQ:CELU) and MuseCell Innovations have entered…
-
Veea Signs Telarus Distribution Agreement to Expand Channel Reach
Veea’s distribution agreement with Telarus gives the company access to a broader network of technology advisors and channel partners, creating a new route to market for its secure connectivity, edge computing and AI-enabled solutions. Key Investor Takeaways Why VEEA Stock Is in Focus Veea (NASDAQ:VEEA) has added Telarus as a distribution partner, giving Telarus’ technology…
-
Alpha Modus Advances Bitcoin Transaction to Add 3,170 BTC to Balance Sheet
Alpha Modus is advancing a strategic transaction expected to add more than $200 million in Bitcoin assets to its balance sheet, with management targeting a significant increase in shareholder equity and a potential resolution of its outstanding Nasdaq listing deficiency. Key Investor Takeaways Why AMOD Stock Is in Focus Alpha Modus (NASDAQ:AMOD) is moving forward…
-
C3is Second-Quarter Revenue Jumps 124% as Shipping Rates Drive Profit Growth
C3is delivered a sharp improvement in second-quarter earnings as higher vessel charter rates lifted revenue and TCE performance, while recent product tanker acquisitions further expand the company’s exposure to the tanker market. Key Investor Takeaways Why CISS Stock Is in Focus C3is (NASDAQ:CISS) reported a substantial improvement in second-quarter operating economics, with voyage revenue rising…